<DOC>
	<DOC>NCT01765621</DOC>
	<brief_summary>Leumit Health Services, an health maintenance organization operating in Israel, will incorporate a web-based, decision support system for handling drug-drug interactions and drug information, termed DDI+ reinforced with patient specific pharmacogenetic data. The investigators hypothesize that implementing such a system will reduce health-care expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).</brief_summary>
	<brief_title>Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions</brief_title>
	<detailed_description />
	<criteria>Number of chronic concomitant drugs â‰¥5 treated with 1 or more drugs with a well established interaction with 1 or more of the following CYP450 enzymes: 2c9, 2c19, 2d6 Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>health care expenditure</keyword>
	<keyword>drug drug interactions</keyword>
	<keyword>electronic decision support systems</keyword>
	<keyword>pharmacogenetics</keyword>
	<keyword>Potential Reduction</keyword>
</DOC>